D. Brisot

Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double-blind, placebo-controlled trial

Marc Righini, J.‐P. Galanaud, H Guenneguez et al. · The Lancet Haematology · 2016 · 168 citations

Thrombosis, Venous Thrombosis, Cardiovascular Disease +8

Comparative study on risk factors and early outcome of symptomatic distal versus proximal deep vein thrombosis: Results from the OPTIMEV study

Marie‐Antoinette Sevestre‐Pietri, J.-P. Laroche, Marc Righini et al. · Thrombosis and Haemostasis · 2009 · 165 citations

Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism

Benjamin Planquette, Laurent Bertoletti, Anaïs Charles‐Nelson et al. · CHEST Journal · 2021 · 142 citations

Thrombosis, Venous Thrombosis, Rivaroxaban Vs Dalteparin +10

Predictive factors for concurrent deep-vein thrombosis and symptomatic venous thromboembolic recurrence in case of superficial venous thrombosis

Céline Genty, Marie-Antoinette Sevestre, D. Brisot et al. · Thrombosis and Haemostasis · 2010 · 106 citations

Using a “non uniform pulse sequence” can improve selective coagulation with a Nd:YAG laser (1.06 μm) thanks to Met‐hemoglobin absorption: A clinical study on blue leg veins

Serge Mordon, D. Brisot, Nathalie Fournier · Lasers in Surgery and Medicine · 2003 · 81 citations